Cellular therapy in lymphoma
Hematol Oncol. 2023 Jun 29. doi: 10.1002/hon.3200. Online ahead…
Target 2035 – an update on private sector contributions
RSC Med Chem. 2023 Mar 16;14(6):1002-1011. doi: 10.1039/d2md00441k.…
Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations
Blood. 2023 Sep 7;142(10):865-877. doi: 10.1182/blood.2023020578.ABSTRACTHematological…
Survival with Axicabtagene Ciloleucel in Large B-Cell Lymphoma
N Engl J Med. 2023 Jul 13;389(2):148-157. doi: 10.1056/NEJMoa2301665.…
Rucaparib for the Treatment of Metastatic Castration-resistant Prostate Cancer Associated with a DNA Damage Repair Gene Alteration: Final Results from the Phase 2 TRITON2 Study
Eur Urol. 2023 Sep;84(3):321-330. doi: 10.1016/j.eururo.2023.05.021.…
Potential angiogenic biomarkers in hereditary hemorrhagic telangiectasia and other vascular diseases
Eur J Intern Med. 2023 Sep;115:10-17. doi: 10.1016/j.ejim.2023.05.020.…
The activities and regulatory landscape of cellular therapies including hematopoietic cell transplantation in the world
Blood Cell Ther. 2022 Dec 23;5(Spec Edition):S15-S24. doi: 10.31547/bct-2022-013.…
Differences in glucose metabolic activity in liver metastasis separates two groups of metastatic uveal melanoma patients with different prognosis
Cancer Med. 2023 Jul;12(13):14062-14071. doi: 10.1002/cam4.6058.…
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants
NPJ Breast Cancer. 2023 May 12;9(1):37. doi: 10.1038/s41523-023-00546-x.ABSTRACTWe…
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis
Leukemia. 2023 Jul;37(7):1511-1520. doi: 10.1038/s41375-023-01924-x.…
Decrease of lethal infectious complications in the context of causes of death (COD) after hematopoietic cell transplantation: COD-2 and COD-1 study of the Infectious Diseases Working Party EBMT
Bone Marrow Transplant. 2023 Aug;58(8):881-892. doi: 10.1038/s41409-023-01998-2.…
An International Survey on Grading, Diagnosis, and Management of Immune Effector Cell-Associated Hematotoxicity (ICAHT) Following CAR T-cell Therapy on Behalf of the EBMT and EHA
Hemasphere. 2023 Apr 27;7(5):e889. doi: 10.1097/HS9.0000000000000889.…
